|
MESDC2 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 4.30989999244957E-09 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
6.20110000015828E-07 |
| Normal-vs-Stage2 |
3.263800E-02 |
| Normal-vs-Stage3 |
7.7254980190844E-11 |
| Normal-vs-Stage4 |
1.21319621015914E-11 |
| Stage1-vs-Stage2 |
2.318600E-01 |
| Stage1-vs-Stage3 |
3.382200E-03 |
| Stage1-vs-Stage4 |
2.763300E-04 |
| Stage2-vs-Stage3 |
6.042100E-03 |
| Stage2-vs-Stage4 |
8.439000E-04 |
| Stage3-vs-Stage4 |
2.732400E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.02189964560296E-10 |
| Normal-vs-AfricanAmerican |
6.664100E-03 |
| Normal-vs-Asian |
3.13200000001679E-06 |
| Caucasian-vs-AfricanAmerican |
6.688600E-01 |
| Caucasian-vs-Asian |
6.379200E-01 |
| AfricanAmerican-vs-Asian |
9.084600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
8.03440000085587E-08 |
| Normal-vs-Female |
1.3420999978031E-08 |
| Male-vs-Female |
5.934800E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
1.41590000002356E-06 |
| Normal-vs-Age(41-60Yrs) |
3.02789999739872E-08 |
| Normal-vs-Age(61-80Yrs) |
8.62460000083942E-08 |
| Normal-vs-Age(81-100Yrs) |
9.52530000000174E-05 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
4.936200E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
2.514400E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
2.021000E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
5.227800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.472800E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.843000E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.95640004196918E-09 |
| Classical-VS-Follicular |
4.419400E-03 |
| Classical-VS-Other |
5.490800E-01 |
| Classical-VS-Normal |
3.99589999977579E-08 |
| Tall-VS-Follicular |
3.892000055572E-10 |
| Tall-VS-Other |
1.604650E-01 |
| Tall-VS-Normal |
<1E-12 |
| Follicular-VS-Other |
1.874800E-01 |
| Follicular-VS-Normal |
7.250300E-02 |
| Other-VS-Normal |
1.616810E-03 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
1.74416999999538E-05 |
| Normal-vs-N1 |
5.14039921739595E-11 |
| N0-vs-N1 |
3.414100E-04 |
|
|
